Clinical trials
Phase 4 Axial Spondyloarthritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Not yet recruiting | 3 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2 |
| CARE ARTHRITIS LTD. | 2 |
| AbbVie | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Charite University, Berlin, Germany | 1 |
| Chinese PLA General Hospital | 1 |
| Columbia University | 1 |
| Hanyang University Seoul Hospital | 1 |
| Pfizer | 1 |
| Professor Mikkel Østergaard | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Axial Spondyloarthritis | 17 |
| Spondylitis, Ankylosing | 4 |
| Arthritis, Psoriatic | 3 |
| Arthritis, Rheumatoid | 2 |
| Spondylarthritis | 2 |
| Uveitis, Anterior | 2 |
| Antiphospholipid Syndrome | 1 |
| Arthritis, Juvenile | 1 |
| Granulomatosis with Polyangiitis | 1 |
| Lupus Erythematosus, Systemic | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.